Evaluation of miRNA Expression in Patients with Gestational Diabetes Mellitus: Investigating Diagnostic Potential and Clinical Implications

References

• Eades CE, Cameron DM, Evans JMM. Prevalence of gestational diabetes mellitus in Europe: a meta-analysis. Diabetes Res Clin Pract. 2017;129:173–181. doi:10.1016/j.diabres.2017.03
   PubMed Web of Science ®Google Scholar
• Hod M, Kapur A, Sacks DA, et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care#. Int J Gynecol Obstet. 2015;131:S173. doi:10.1016/S0020-7292(15)30007-2
   PubMed Web of Science ®Google Scholar
• Caughey AB, Turrentine M. ACOG practice bulletin no. 190: gestational diabetes mellitus. Obstetrics Gynecol. 2018;131(2):e49. doi:10.1097/AOG.0000000000002501
   PubMedGoogle Scholar
• Alejandro EU, Mamerto TP, Chung G, et al. Gestational diabetes mellitus: a harbinger of the vicious cycle of diabetes. Int J Mol Sci. 2020;21(14):5003. doi:10.3390/ijms21145003
   PubMed Web of Science ®Google Scholar
• Szmuilowicz ED, Josefson JL, Metzger BE. Endocrinology and METABOLISM CLInics of North America. Gestational Diabetes Mellitus. 2019;48(3):479–493. doi:10.1016/j.ecl.2019.05.001
   Google Scholar
• Yu Y, Arah OA, Liew Z, et al. Maternal diabetes during pregnancy and early onset of cardiovascular disease in offspring: population based cohort study with 40 years of follow-up. BMJ. 2019:l6398. doi:10.1136/bmj.l6398
   PubMedGoogle Scholar
• Metzger BE, Lowe LP; HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002. doi:10.1056/NEJMoa0707943
   PubMed Web of Science ®Google Scholar
• Metzger BE, Persson B, Lowe LP, et al. Hyperglycemia and adverse pregnancy outcome study: neonatal glycemia. Pediatrics. 2010;126(6):e1545–e1552. doi:10.1542/peds.2009-2257
   PubMed Web of Science ®Google Scholar
• Reece EA. The fetal and maternal consequences of gestational diabetes mellitus. J Matern Fetal Neonatal Med. 2010;23(3):199–203. doi:10.3109/14767050903550659
   PubMed Web of Science ®Google Scholar
• Ornoy A, Becker M, Weinstein-Fudim L, Ergaz Z. Diabetes during pregnancy: a maternal disease complicating the course of pregnancy with long-term deleterious effects on the offspring. A clinical review. Int J Mol Sci. 2021;22(6):2965. doi:10.3390/ijms22062965
   PubMed Web of Science ®Google Scholar
• Atègbo JM, Grissa O, Yessoufou A, et al. Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab. 2006;91(10):4137–4143. doi:10.1210/jc.2006-0980
   PubMed Web of Science ®Google Scholar
• Mattick JS, Lee JT. The genetic signatures of noncoding RNAs. PLoS Genet. 2009;5(4):e1000459. doi:10.1371/journal.pgen.1000459
   PubMed Web of Science ®Google Scholar
• Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843–854. doi:10.1016/0092-8674(93)90529-y
   PubMed Web of Science ®Google Scholar
• He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5(7):522–531. doi:10.1038/nrg1379
   PubMed Web of Science ®Google Scholar
• Vishnoi A, Rani S. MiRNA biogenesis and regulation of diseases: an overview. In: Rani S, editor. MicroRNA Profiling. Vol 1509. Methods in Molecular Biology. New York: Springer; 2017:1–10. doi:10.1007/978-1-4939-6524-3_1
   Google Scholar
• Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA. MicroRNAs in body fluids—the mix of hormones and biomarkers. Nat Rev Clin Oncol. 2011;8(8):467–477. doi:10.1038/nrclinonc.2011.76
   PubMed Web of Science ®Google Scholar
• Lu J, Clark AG. Impact of microRNA regulation on variation in human gene expression. Genome Res. 2012;22(7):1243–1254. doi:10.1101/gr.132514.111
   PubMed Web of Science ®Google Scholar
• Okamura K, Hagen JW, Duan H, Tyler DM, Lai EC. The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila. Cell. 2007;130(1):89–100. doi:10.1016/j.cell.2007.06.028
   PubMed Web of Science ®Google Scholar
• Isik M, Berezikov E. Expression pattern analysis of microRNAs in Caenorhabditis elegans. Methods Mol Biol. 2013;936:129–141. doi:10.1007/978-1-62703-083-0_11
   PubMedGoogle Scholar
• Selvakumar SC, Preethi KA, Tusubira D, Sekar D. MicroRNAs in the epigenetic regulation of disease progression in Parkinson’s disease. Front Cell Neurosci. 2022;16. doi:10.3389/fncel.2022.995997
   PubMed Web of Science ®Google Scholar
• Hsiao KY, Sun HS, Tsai SJ. Circular RNA – new member of noncoding RNA with novel functions. Exp Biol Med. 2017;242(11):1136–1141. doi:10.1177/1535370217708978
   PubMed Web of Science ®Google Scholar
• Zheng Q, Bao C, Guo W, et al. Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs. Nat Commun. 2016;7(1):11215. doi:10.1038/ncomms11215
   PubMed Web of Science ®Google Scholar
• Turchinovich A, Weiz L, Burwinkel B. Extracellular miRNAs: the mystery of their origin and function. Trends Biochem Sci. 2012;37(11):460–465. doi:10.1016/j.tibs.2012.08.003
   PubMed Web of Science ®Google Scholar
• Wittmann J, Jäck HM. Serum microRNAs as powerful cancer biomarkers. Biochim Biophys Acta Rev Cancer. 2010;1806(2):200–207. doi:10.1016/j.bbcan.2010.07.002
   PubMed Web of Science ®Google Scholar
• Jayabalan N, Nair S, Nuzhat Z, et al. Cross talk between adipose tissue and placenta in obese and gestational diabetes mellitus pregnancies via exosomes. Front Endocrinol. 2017;8:239. doi:10.3389/fendo.2017.00239
   PubMed Web of Science ®Google Scholar
• McDonald JS, Milosevic D, Reddi HV, Grebe SK, Algeciras-Schimnich A. Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem. 2011;57(6):833–840. doi:10.1373/clinchem.2010.157198
   PubMed Web of Science ®Google Scholar
• Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18(10):997–1006. doi:10.1038/cr.2008.282
   PubMed Web of Science ®Google Scholar
• Assmann TS, Recamonde-Mendoza M, De Souza BM, Crispim D. MicroRNA expression profiles and type 1 diabetes mellitus: systematic review and bioinformatic analysis. Endocr Connect. 2017;6(8):773–790. doi:10.1530/EC-17-0248
   PubMed Web of Science ®Google Scholar
• Satake E, Pezzolesi MG, Md Dom ZI, Smiles AM, Niewczas MA, Krolewski AS. Circulating miRNA profiles associated with hyperglycemia in patients with type 1 diabetes. Diabetes. 2018;67(5):1013–1023. doi:10.2337/db17-1207
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bai R, Liu C, et al. MicroRNA single‐nucleotide polymorphisms and diabetes mellitus: a comprehensive review. Clin Genet. 2019;95(4):451–461. doi:10.1111/cge.13491
   PubMed Web of Science ®Google Scholar
• Yang Z, Chen H, Si H, et al. Serum miR-23a, a potential biomarker for diagnosis of pre-diabetes and type 2 diabetes. Acta Diabetol. 2014;51(5):823–831. doi:10.1007/s00592-014-0617-8
   PubMed Web of Science ®Google Scholar
• Prabu P, Rome S, Sathishkumar C, et al. MicroRNAs from urinary extracellular vesicles are non-invasive early biomarkers of diabetic nephropathy in type 2 diabetes patients with the “Asian Indian phenotype”. Diabetes Metab. 2019;45(3):276–285. doi:10.1016/j.diabet.2018.08.004
   PubMed Web of Science ®Google Scholar
• Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, Ghaffari SH. An overview of microRNAs: biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019;234(5):5451–5465. doi:10.1002/jcp.27486
   PubMed Web of Science ®Google Scholar
• Gao X, Zhao S. miRNA-16-5p inhibits the apoptosis of high glucose-induced pancreatic β cells via targeting of CXCL10: potential biomarkers in type 1 diabetes mellitus. Endokrynologia Polska. 2020;71(5):404–410. doi:10.5603/EP.a2020.0046
   PubMed Web of Science ®Google Scholar
• Chakraborty C, George Priya Doss C, Bandyopadhyay S. miRNAs in insulin resistance and diabetes-associated pancreatic cancer: the “minute and miracle” molecule moving as a monitor in the “genomic galaxy”. Curr Drug Targets. 2013;14(10):1110–1117. doi:10.2174/13894501113149990182
   PubMed Web of Science ®Google Scholar
• da Silva PHCM. MicroRNAs associated with the pathophysiological mechanisms of gestational diabetes mellitus: a systematic review for building a panel of miRNAs. J Pers Med. 2023;13(7):1126. doi:10.3390/jpm13071126
   PubMed Web of Science ®Google Scholar
• Radojičić O, Dobrijević Z, Robajac D, et al. Gestational diabetes is associated with an increased expression of miR-27a in peripheral blood mononuclear cells. Mol Diagn Ther. 2022;26(4):421–435. doi:10.1007/s40291-022-00591-5
   PubMed Web of Science ®Google Scholar
• Miller TE, Ghoshal K, Ramaswamy B, et al. MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol Chem. 2008;283(44):29897–29903. doi:10.1074/jbc.M804612200
   PubMed Web of Science ®Google Scholar
• Shi Z, Zhao C, Guo X, et al. Differential expression of microRNAs in omental adipose tissue from gestational diabetes mellitus subjects reveals miR-222 as a regulator of ERα expression in estrogen-induced insulin resistance. Endocrinology. 2014;155(5):1982–1990. doi:10.1210/en.2013-2046
   PubMed Web of Science ®Google Scholar
• Filardi T, Catanzaro G, Grieco GE, et al. Identification and validation of miR-222-3p and miR-409-3p as plasma biomarkers in gestational diabetes mellitus sharing validated target genes involved in metabolic homeostasis. IJMS. 2022;23(8):4276. doi:10.3390/ijms23084276
   Google Scholar
• Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005;65(14):6029–6033. doi:10.1158/0008-5472.CAN-05-0137
   PubMed Web of Science ®Google Scholar
• Liu S, Wu W, Liao J, et al. MicroRNA-21: a critical pathogenic factor of diabetic nephropathy. Front Endocrinol. 2022;13:895010. doi:10.3389/fendo.2022.895010
   PubMed Web of Science ®Google Scholar
• Krichevsky AM, Gabriely G. miR-21: a small multi-faceted RNA. J Cell Mol Med. 2009;13(1):39–53. doi:10.1111/j.1582-4934.2008.00556.x
   PubMed Web of Science ®Google Scholar
• Ruan Q, Wang T, Kameswaran V, et al. The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic beta cell death. Proc Natl Acad Sci U S A. 2011;108(29):12030–12035. doi:10.1073/pnas.1101450108
   PubMed Web of Science ®Google Scholar
• Sicard F, Gayral M, Lulka H, Buscail L, Cordelier P. Targeting miR-21 for the therapy of pancreatic cancer. Mol Ther. 2013;21(5):986–994. doi:10.1038/mt.2013.35
   PubMed Web of Science ®Google Scholar
• Cao YL, Jia YJ, Xing BH, Shi DD, Dong XJ. Plasma microRNA-16-5p, −17-5p and −20a-5p: novel diagnostic biomarkers for gestational diabetes mellitus. J Obstet Gynaecol Res. 2017;43(6):974–981. doi:10.1111/jog.13317
   PubMed Web of Science ®Google Scholar
• Hocaoglu M, Demirer S, Loclar Karaalp I, et al. Identification of miR-16-5p and miR-155-5p microRNAs differentially expressed in circulating leukocytes of pregnant women with polycystic ovary syndrome and gestational diabetes. Gynecol Endocrinol. 2021;37(3):216–220. doi:10.1080/09513590.2020.1843620
   PubMed Web of Science ®Google Scholar
• Hocaoglu M, Demirer S, Senturk H, Turgut A, Komurcu-Bayrak E. Differential expression of candidate circulating microRNAs in maternal blood leukocytes of the patients with preeclampsia and gestational diabetes mellitus. Pregnancy Hypertens. 2019;17:5–11. doi:10.1016/j.preghy.2019.04.004
   PubMed Web of Science ®Google Scholar
• Zhu Y, Tian F, Li H, Zhou Y, Lu J, Ge Q. Profiling maternal plasma microRNA expression in early pregnancy to predict gestational diabetes mellitus. Int J Gynaecol Obstet. 2015;130(1):49–53. doi:10.1016/j.ijgo.2015.01.010
   PubMed Web of Science ®Google Scholar
• Juchnicka I, Kuźmicki M, Niemira M, et al. miRNAs as predictive factors in early diagnosis of gestational diabetes mellitus. Front Endocrinol. 2022;13:839344. doi:10.3389/fendo.2022.839344
   PubMed Web of Science ®Google Scholar
• Pheiffer C, Dias S, Rheeder P, Adam S. Decreased expression of circulating miR-20a-5p in South African women with gestational diabetes mellitus. Mol Diagn Ther. 2018;22(3):345–352. doi:10.1007/s40291-018-0325-0
   PubMed Web of Science ®Google Scholar
• Martínez-Ibarra A, Martínez-Razo LD, Vázquez-Martínez ER, et al. Unhealthy levels of phthalates and bisphenol A in Mexican pregnant women with gestational diabetes and its association to altered expression of miRNAs involved with metabolic disease. IJMS. 2019;20(13):3343. doi:10.3390/ijms20133343
   Google Scholar
• Balci S, Gorur A, Yıldırım DD, Cayan F, Tamer L. Expression level of miRNAS in patients with gestational diabetes. Turk JBiochem. 2020;45(6):825–831. doi:10.1515/tjb-2019-0157
   Google Scholar
• Tagoma A, Alnek K, Kirss A, Uibo R, Haller-Kikkatalo K. MicroRNA profiling of second trimester maternal plasma shows upregulation of miR-195-5p in patients with gestational diabetes. Gene. 2018;672:137–142. doi:10.1016/j.gene.2018.06.004
   PubMed Web of Science ®Google Scholar
• Wander PL, Boyko EJ, Hevner K, et al. Circulating early- and mid-pregnancy microRNAs and risk of gestational diabetes. Diabet Res Clin Pract. 2017;132:1–9. doi:10.1016/j.diabres.2017.07.024
   PubMed Web of Science ®Google Scholar